Peak Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Peak Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q4 2023.
- Peak Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$1.15M, a 78% increase year-over-year.
- Peak Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$13.1M, a 10.3% decline year-over-year.
- Peak Bio, Inc. annual Operating Income (Loss) for 2023 was -$13.1M, a 10.3% decline from 2022.
- Peak Bio, Inc. annual Operating Income (Loss) for 2022 was -$11.8M, a 30.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)